Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma.
Handley KF, Mehta S, Martin AL, Biswas S, Maharaj K, Nagy MZ, Mine JA, Cortina C, Yu X, Sprenger K, Mandal G, Innamarato P, Powers JJ, Harro CM, Chaurio RA, Anadon CM, Shahzad MM, Flores I, Conejo-Garcia JR.
Handley KF, et al. Among authors: maharaj k.
Gynecol Oncol. 2023 Jun;173:114-121. doi: 10.1016/j.ygyno.2023.03.020. Epub 2023 Apr 28.
Gynecol Oncol. 2023.
PMID: 37121178
Free PMC article.